Bayer | BAYN - Loan Capital

Stock Price
42.01
Daily Change
0.17 0.39%
Monthly
-7.04%
Yearly
84.98%
Q1 Forecast
42.20

Bayer reported EUR32.71B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Air Liquide EUR 11.06B 1.39B Dec/2025
Akzo Nobel EUR 3.67B 13M Dec/2025
Alcon AG USD 4.59B 73M Sep/2025
Arkema EUR 3.8B 312M Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 32.71B 1B Sep/2025
Beiersdorf EUR 132M 20M Jun/2025
Corteva USD 1.69B 2M Dec/2025
Covestro EUR 2.08B 35M Sep/2025
Essilor EUR 9.46B 92M Dec/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Fresenius Medical Care EUR 4.85B 4.49B Dec/2025
Genmab DKK 126M 6M Sep/2025
Givaudan CHF 4.29B 175M Jun/2024
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 9.09B 1.64B Sep/2025
Henkel EUR 2.01B 40M Jun/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Johnson Matthey GBP 1.34B 3M Dec/2025
Linde USD 18.59B 1.11B Sep/2025
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 10.45B 4.15B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Nutrien USD 10.29B 519M Dec/2025
Philips EUR 6.93B 303M Dec/2025
PPG Industries USD 6.6B 698M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
SAP EUR 6.02B 68M Dec/2025
Solvay EUR 1.84B 209M Dec/2025
UCB EUR 2.82B 146M Jun/2025
Umicore EUR 2.24B 10M Dec/2025
Vinci EUR 41.93B 11.14B Dec/2025